Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,030.00p
   
  • Change Today:
      32.00p
  • 52 Week High: 2,155.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.04m
  • Volume: 214,697
  • Market Cap: £1,340.55m
  • RiskGrade: 128
  • Beta: 0.05

Regulatory News

Appointment of Financial Adviser & joint Broker 09-May-2025 09:25 RNS
Total Voting Rights 01-May-2025 14:28 RNS
PRRS Resistant Pig – FDA Approval 30-Apr-2025 07:00 RNS
Notification of Major Holdings 25-Apr-2025 16:30 RNS
Notification of Major Holdings 25-Apr-2025 16:28 RNS
Director/PDMR Shareholding 02-Apr-2025 17:08 RNS
Notification of Major Holdings 02-Apr-2025 15:43 RNS
Appointment of Chief Financial Officer Designate 13-Mar-2025 07:00 RNS
Total Voting Rights 03-Mar-2025 11:32 RNS
Director/PDMR Shareholding 28-Feb-2025 13:30 RNS
Interim Results 27-Feb-2025 07:00 RNS
Non-Executive Director Retirement 26-Feb-2025 07:00 RNS
Block Listing Six Monthly Return 03-Feb-2025 15:17 RNS
Total Voting Rights 03-Feb-2025 09:40 RNS
Half Year Trading Update – Ahead of expect... 15-Jan-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,030.00p
Change Today 32.00p
% Change 1.60 %
52 Week High 2,155.00
52 Week Low 1,424.00
Volume 214,697
Shares Issued 66.04m
Market Cap £1,340.55m
Beta 0.05
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.96% below the market average88.96% below the market average88.96% below the market average88.96% below the market average88.96% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Price Trend
45.45% above the market average45.45% above the market average45.45% above the market average45.45% above the market average45.45% above the market average
74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average
Income
92.91% below the market average92.91% below the market average92.91% below the market average92.91% below the market average92.91% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
92.35% below the market average92.35% below the market average92.35% below the market average92.35% below the market average92.35% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 1
Sell 0
Strong Sell 0
Total 10
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 07-Nov-24
Paid 04-Apr-25 06-Dec-24
Amount 10.30p 21.70p

Trades for 23-May-2025

Time Volume / Share Price
16:35 150 @ 2,030.00p
16:20 40 @ 2,010.00p
16:20 46 @ 2,007.50p
16:02 4 @ 2,005.00p
16:02 30 @ 2,010.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page